Multiple choice questions
Panel: V. Georgoulias (GR). E. Kourea (GR)
The role of tumor microenvironment as a biomarker for immunotherapy response K. Kosmatopoulos (FR)
Panel: G. Bamias (GR), S. Sakellariou
The role of microenvironment in Inflammatory bowel disease as a biomarker for clinical outcome and treatment response A. Sourla (GR)
Panel: M. Dougan (US). P. Verginis (GR)
Adverse effects of immune checkpoint inhibitors treatment: the role of pathologists
I. Pateras (GR)
Multiple choice questions